Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ginevra Fiori

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Rheumatology|February 3, 2022
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseasesCosimo Bruni, Cosimo Cigolini, Giulia Tesei, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 17, 2018
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated DisordersFrancesca Nencini, Alessandra Vultaggio, Sara Pratesi, et al.
Rheumatology (Oxford, England)|July 28, 2014
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosisCosimo Bruni, Serena Guiducci, Silvia Bellando-Randone, et al.
Journal of Clinical Medicine|May 7, 2020
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint DiseasesLaura Cometi, Cosimo Bruni, Nicolò Chiti, et al.
Rheumatology and Immunology Research|December 5, 2022
Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center ExperienceLaura Cometi, Cosimo Bruni, Saverio Passavanti, et al.
Therapeutic Advances in Musculoskeletal Disease|November 2, 2020
The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseasesCosimo Bruni, Stefano Gentileschi, Giovanni Pacini, et al.
Journal of Pineal Research|August 2, 2006
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosisAlberto Moggi Pignone, Angela Del Rosso, Ginevra Fiori, et al.
Clinical and Experimental Rheumatology|October 3, 2018
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interactionGinevra Fiori, Tessa Marzi, Francesca Bartoli, et al.
Rheumatology (Oxford, England)|April 20, 2010
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesionsLaura Amanzi, Francesca Braschi, Ginevra Fiori, et al.
The Journal of Infection|October 30, 2012
Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatmentFilippo Bartalesi, Delia Goletti, Michele Spinicci, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Rheumatology|February 3, 2022
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseasesCosimo Bruni, Cosimo Cigolini, Giulia Tesei, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 17, 2018
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated DisordersFrancesca Nencini, Alessandra Vultaggio, Sara Pratesi, et al.
Rheumatology (Oxford, England)|July 28, 2014
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosisCosimo Bruni, Serena Guiducci, Silvia Bellando-Randone, et al.
Journal of Clinical Medicine|May 7, 2020
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint DiseasesLaura Cometi, Cosimo Bruni, Nicolò Chiti, et al.
Rheumatology and Immunology Research|December 5, 2022
Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center ExperienceLaura Cometi, Cosimo Bruni, Saverio Passavanti, et al.
Therapeutic Advances in Musculoskeletal Disease|November 2, 2020
The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseasesCosimo Bruni, Stefano Gentileschi, Giovanni Pacini, et al.
Journal of Pineal Research|August 2, 2006
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosisAlberto Moggi Pignone, Angela Del Rosso, Ginevra Fiori, et al.
Clinical and Experimental Rheumatology|October 3, 2018
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interactionGinevra Fiori, Tessa Marzi, Francesca Bartoli, et al.
Rheumatology (Oxford, England)|April 20, 2010
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesionsLaura Amanzi, Francesca Braschi, Ginevra Fiori, et al.
The Journal of Infection|October 30, 2012
Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatmentFilippo Bartalesi, Delia Goletti, Michele Spinicci, et al.
Pageof 3